BEVAN, P. S.;ELLIS, G. P., J. CHEM. SOC. PERKIN TRANS., 1983, N 8, 1705-1709
作者:BEVAN, P. S.、ELLIS, G. P.
DOI:——
日期:——
BEVAN P. S.; ELLIS G. P.; HUDSON H. V.; ROMNEY-ALEXANDER T. M.; WILLIAMS +, J. CHEM. SOC. PERKIN TRANS.,(1986) N 9, 1643-1649
作者:BEVAN P. S.、 ELLIS G. P.、 HUDSON H. V.、 ROMNEY-ALEXANDER T. M.、 WILLIAMS +
DOI:——
日期:——
THERAPEUTIC CHROMAN COMPOUNDS
申请人:AstraZeneca AB
公开号:EP1353915A2
公开(公告)日:2003-10-22
[EN] THERAPEUTIC CHROMAN COMPOUNDS<br/>[FR] COMPOSES THERAPEUTIQUES DE CHROMANE
申请人:ASTRAZENECA AB
公开号:WO2002055014A2
公开(公告)日:2002-07-18
Provided herein is a compound represented by the Formula (I) wherein said compounds are useful for the treatment of migraine. Also provided are processes for the preparation of compounds of Formula (I) and intermediates.
Bevan, Peter S.; Ellis, Gwynn P.; Hudson, Henrietta V., Journal of the Chemical Society. Perkin transactions I, 1986, p. 1643 - 1650
作者:Bevan, Peter S.、Ellis, Gwynn P.、Hudson, Henrietta V.、Romney-Alexander, Trevor M.、Williams, J. Michael